MedImmune begins asthma drug trial (Pharmaceutical Business Review)
MedImmune has initiated a multi-dose, phase IIa clinical trial with its monoclonal antibody targeting interleukin-9 in adults with mild, persistent asthma.
Opinion by Bonnie Henry : Another time in Tucson (Arizona Daily Star)
It may be the strangest "war effort" story I've ever heard.
Opinion by Bonnie Henry : Another time in Tucson (Arizona Daily Star)
It may be the strangest "war effort" story I've ever heard.
Original post: MedImmune begins asthma drug trial (Pharmaceutical Business Review) by Copyright (c) 2004 Yahoo! Inc. All rights reserved. at Yahoo! News Search Results for adult asthma
Blog tag: Adult asthma
Technorati tag: Adult asthma